Evonik to Invest US$89 Million (€80 Million) in Slovenska Lupca, Slovakia
Introduction:
Evonik has started construction of a biotechnology expansion at its Fermas site in Slovenska Lupca, Slovakia, as part of an investment of US$89 million (€80 million).
Features:
The project involves expanding biotechnology manufacturing capabilities at the existing Fermas site in Slovenska Lupca, Slovakia. The development will include new downstream fermentation technology to support the production of complex pharmaceutical intermediates.
The expansion will increase downstream processing capacity, including processes used to separate, recover and purify products obtained through fermentation. These processes support the manufacture of pharmaceutical ingredients and other complex molecules.
The project will strengthen the site's contract development and manufacturing capabilities for drug substances, supporting production activities that use biotechnology and fermentation processes.
The site already has more than three decades of fermentation experience, with production activities serving the pharmaceutical, personal care, nutrition and speciality chemical industries.
The facility operates using 100% green electricity and uses renewable and certified raw materials in selected production processes. The expansion will add to the site's existing biotechnology infrastructure.
Construction is expected to be completed in early 2028.
Specifications:
Name: Evonik
Type: New Construction
Budget: US$89 million (€80 million)
Year: 2028